Hong Kong vs Kuwait: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong
100.0%
in 2024
Kuwait
100.0%
in 2023
Hong Kong rank
1st
Kuwait rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong
- Kuwait
How they compare
Hong Kong currently reports 100.0% against 100.0% in Kuwait, a difference of 0.0%.
Across all 15 years both countries report, Kuwait has been ahead every year.
Hong Kong ranks 1st and Kuwait ranks 1st of 144 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hong Kong | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.4% | 100.0% | 46.6% | Kuwait |
| 2010s | 26.6% | 100.0% | 73.4% | Kuwait |
| 2020s | 90.2% | 100.0% | 9.8% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong or Kuwait?
- Hong Kong, at 100.0% against 100.0% in Kuwait as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong and Kuwait?
- 0.0%, with Hong Kong ahead.
- How many years of comparable data are there for Hong Kong and Kuwait?
- 15 years are reported by both, from 2003 to 2023.
- How do Hong Kong and Kuwait rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong ranks 1st and Kuwait ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.